DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 51 filers reported holding DYNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,710 | -20.4% | 11,364 | +0.1% | 0.00% | – |
| Q2 2023 | $127,799 | -2.0% | 11,350 | +0.1% | 0.00% | – |
| Q1 2023 | $130,458 | -98.7% | 11,339 | -99.3% | 0.00% | -100.0% |
| Q3 2022 | $9,735,726 | +33.5% | 1,531,906 | +44.5% | 0.01% | +40.0% |
| Q2 2022 | $7,293,000 | -35.9% | 1,060,301 | -10.3% | 0.01% | 0.0% |
| Q1 2022 | $11,386,000 | +64.5% | 1,182,706 | +103.1% | 0.01% | +66.7% |
| Q4 2021 | $6,923,000 | -23.7% | 582,298 | +4.3% | 0.00% | -25.0% |
| Q3 2021 | $9,070,000 | -24.0% | 558,483 | -1.5% | 0.00% | -20.0% |
| Q2 2021 | $11,933,000 | -11.1% | 567,166 | -34.4% | 0.01% | -16.7% |
| Q1 2021 | $13,419,000 | +1.5% | 864,074 | +37.2% | 0.01% | 0.0% |
| Q4 2020 | $13,227,000 | -33.6% | 629,852 | -36.1% | 0.01% | -40.0% |
| Q3 2020 | $19,912,000 | – | 985,963 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |